Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach Or Graft alpha/beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL)

Authors

Hisham Abdel-Azim
Christopher C. Dvorak
Nancy Bunin
Mark C. Walters
Julie-An Talano
Eric J. Anderson
Jemily Malvar
May A. Jasani
Sonali Chaudhury
Mitchell S. Cairo, New York Medical CollegeFollow
Carrie Kitko
Allison P. Jacob
Dimitri S. Monos
Leung Wing
Michael A. Pulsipher

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

11-2019

Journal Title

Blood

Department

Pediatrics

Second Department

Health Behavior and Community Health

Recommended Citation

Abdel-Azim, H., Dvorak, C. C., Bunin, N., Walters, M. C., Talano, J., Anderson, E. J., Malvar, J., Jasani, M. A., Chaudhury, S., Cairo, M. S., Kitko, C., Jacob, A. P., Monos, D. S., Wing, L., & Pulsipher, M. A. (2019). Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Preparative Approach Or Graft alpha/beta Depletion in Children with Acute Lymphoblastic Leukemia (ALL). Blood, 134 (Suppl. 1), 4624. https://doi.org/10.1182/blood-2019-131706